Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido R Y De Meyer

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Circulation Research|February 14, 2009
Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potentialWim Martinet, Guido R Y De Meyer
Current Atherosclerosis Reports|May 21, 2008
Autophagy in atherosclerosisWim Martinet, Guido R Y De Meyer
Biochimica Et Biophysica Acta|January 21, 2009
Autophagy in the cardiovascular systemGuido R Y De Meyer, Wim Martinet
Cells|July 1, 2017
Standard Immunohistochemical Assays to Assess Autophagy in Mammalian TissueWim Martinet, Lynn Roth, Guido R Y De Meyer
British Journal of Clinical Pharmacology|November 10, 2015
Potential therapeutic effects of mTOR inhibition in atherosclerosisAmmar Kurdi, Guido R Y De Meyer, Wim Martinet
Autophagy|January 17, 2007
Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagyWim Martinet, Stefan Verheye, Guido R Y De Meyer
Transplantation|February 24, 2017
mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and AtherosclerosisAmmar Kurdi, Wim Martinet, Guido R Y De Meyer
Trends in Cardiovascular Medicine|February 13, 2007
Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell deathWim Martinet, Stefan Verheye, Guido R Y De Meyer
Current Vascular Pharmacology|June 3, 2009
Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complicationsValerie Croons, Wim Martinet, Guido R Y De Meyer
EMBO Molecular Medicine|July 31, 2025
SMAD7: riding on fibrosis-limiting routes and beyondLeonardo Martin, Giulio Gabbiani, Guido R Y De Meyer
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Circulation Research|February 14, 2009
Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potentialWim Martinet, Guido R Y De Meyer
Current Atherosclerosis Reports|May 21, 2008
Autophagy in atherosclerosisWim Martinet, Guido R Y De Meyer
Biochimica Et Biophysica Acta|January 21, 2009
Autophagy in the cardiovascular systemGuido R Y De Meyer, Wim Martinet
Cells|July 1, 2017
Standard Immunohistochemical Assays to Assess Autophagy in Mammalian TissueWim Martinet, Lynn Roth, Guido R Y De Meyer
British Journal of Clinical Pharmacology|November 10, 2015
Potential therapeutic effects of mTOR inhibition in atherosclerosisAmmar Kurdi, Guido R Y De Meyer, Wim Martinet
Autophagy|January 17, 2007
Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagyWim Martinet, Stefan Verheye, Guido R Y De Meyer
Transplantation|February 24, 2017
mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and AtherosclerosisAmmar Kurdi, Wim Martinet, Guido R Y De Meyer
Trends in Cardiovascular Medicine|February 13, 2007
Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell deathWim Martinet, Stefan Verheye, Guido R Y De Meyer
Current Vascular Pharmacology|June 3, 2009
Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complicationsValerie Croons, Wim Martinet, Guido R Y De Meyer
EMBO Molecular Medicine|July 31, 2025
SMAD7: riding on fibrosis-limiting routes and beyondLeonardo Martin, Giulio Gabbiani, Guido R Y De Meyer
Pageof 20